Synergistic integration of histone deacetylase inhibitors apparently enhances the cytokine‐induced killer cell efficiency in multiple myeloma via the NKG2D pathway.

MLA

Pu, Jingjing, et al. “Synergistic Integration of Histone Deacetylase Inhibitors Apparently Enhances the Cytokine‐induced Killer Cell Efficiency in Multiple Myeloma via the NKG2D Pathway.” Clinical & Translational Immunology, vol. 13, no. 3, Mar. 2024, pp. 1–13. EBSCOhost, https://doi.org/10.1002/cti2.1500.

APA

Pu, J., Sharma, A., Liu, T., Hou, J., & Schmidt, W. I. G. (2024). Synergistic integration of histone deacetylase inhibitors apparently enhances the cytokine‐induced killer cell efficiency in multiple myeloma via the NKG2D pathway. Clinical & Translational Immunology, 13(3), 1–13. https://doi.org/10.1002/cti2.1500

Chicago

Pu, Jingjing, Amit Sharma, Ting Liu, Jian Hou, and Wolf, Ingo GH Schmidt. 2024. “Synergistic Integration of Histone Deacetylase Inhibitors Apparently Enhances the Cytokine‐induced Killer Cell Efficiency in Multiple Myeloma via the NKG2D Pathway.” Clinical & Translational Immunology 13 (3): 1–13. doi:10.1002/cti2.1500.